The liver as a crucial organ in the first line of host defense:: the roles of Kupffer cells, natural killer (NK) cells and NK1.1 Ag+ T cells in T helper 1 immune responses

被引:278
|
作者
Seki, S [1 ]
Habu, Y
Kawamura, T
Takeda, K
Dobashi, H
Ohkawa, T
Hiraide, H
机构
[1] Natl Def Med Coll, Inst Res, Div Basic Traumatol, Tokorozawa, Saitama 3598513, Japan
[2] Niigata Univ, Sch Med, Dept Immunol, Niigata, Japan
[3] Juntendo Univ, Sch Med, Dept Immunol, Bunkyo Ku, Tokyo 113, Japan
[4] Natl Def Med Coll, Inst Res, Dept Pediat, Tokorozawa, Saitama, Japan
关键词
D O I
10.1034/j.1600-0528.2002.017404.x
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The Liver remains a hematopoietic organ after birth and can produce all leukocyte lineages from resident hematopoietic stem cells. Hepatocytes produce acute phase proteins and complement in bacterial infections. Liver Kupffer cells are activated by various bacterial stimuli, including bacterial lipopolysaccharide (LPS) and bacterial superantigens, and produce interleukin (IL)-12. IL-12 and other monokines (IL-18 etc.) produced by Kupffer cells activate liver natural killer (NK) cells and NK1.1 Ag+T cells to produce interferon-gamma and thereby acquire cytotoxicity against tumors and microbe-infected cells. These liver leukocytes and the T helper 1 immune responses induced by them thus play a crucial role in the first line of defense against bacterial infections and hematogenous tumor metastases. However, if this defense system is inadequately activated, shock associated with multiple organ failure takes place. Activated liver NK1.1 Ag+T cells and NK cells also cause hepatocyte injury. NK1.1 Ag+ Teens and another T-cell subset with an intermediate T-cell receptor, CD 122(+)CD8(+) T cells, can develop independently of thymic epithelial cells. Liver NK cells and NK1.1 Ag+ T cells physiologically develop in situ from their precursors, presumably due to bacterial antigens brought from the intestine via the portal vein. NK cells activated by bacterial superantigens or LPS are also probably involved in the vascular endothelial injury in Kawasaki disease.
引用
收藏
页码:35 / 46
页数:12
相关论文
共 50 条
  • [21] Reactivation of Epstein-Barr Virus Hepatitis in T/Natural Killer (NK) Cells Mimicking Liver T/NK-Cell Lymphoma
    Kwong, Sara
    Lu, Xiangping
    Liu, Xiuli
    Lai, Jinping
    GASTROENTEROLOGY RESEARCH, 2020, 13 (02) : 81 - 84
  • [22] Stringent V beta requirement for the development of NK1.1(+) T cell receptor-alpha/beta(+) cells in mouse liver
    Ohteki, T
    MacDonald, HR
    JOURNAL OF EXPERIMENTAL MEDICINE, 1996, 183 (03): : 1277 - 1282
  • [23] Natural killer cells in MS patients: Changes in regulatory NK and NK-T cells are observed with IFN-beta-1a (Avonex) treatment
    Goelz, SE
    Deng, J
    Waubant, E
    Lacy, J
    Bennett, D
    Sandrock, A
    Kantor, AB
    NEUROLOGY, 2006, 66 (05) : A173 - A173
  • [24] NK1.1- natural killer T cells upregulate interleukin-17 expression in experimental lupus nephritis
    An, Jung Nam
    Ryu, Seungwon
    Kim, Yong Chul
    Yoo, Kyung Don
    Lee, Jangwook
    Kim, Hye Young
    Lee, Hajeong
    Lee, Jung Pyo
    Lee, Jae Wook
    Jeon, Un Sil
    Kim, Dong Ki
    Kim, Yon Su
    Yang, Seung Hee
    AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, 2021, 320 (05) : F772 - F788
  • [25] V alpha 24+, V beta 11+ natural T cells are the human analog of murine NK1.1 T cells and demonstrate a predominant Th1 phenotype.
    Prussin, C
    Foster, B
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1997, 99 (01) : 1049 - 1049
  • [26] Natural killer-like T cells develop in SJL mice despite genetically distinct defects in NK1.1 expression and in inducible interleukin-4 production
    Beutner, U
    Launois, P
    Ohteki, T
    Louis, JA
    MacDonald, HR
    EUROPEAN JOURNAL OF IMMUNOLOGY, 1997, 27 (04) : 928 - 934
  • [27] CD1-dependent natural killer (NK1.1+) T cells are required for oral and portal venous tolerance induction
    Margenthaler, JA
    Landeros, K
    Kataoka, M
    Flye, MW
    JOURNAL OF SURGICAL RESEARCH, 2002, 104 (01) : 29 - 35
  • [28] Natural killer cells in MS patients: Changes in regulatory NK and NK-T-cells are observed with IFN-Beta-1a (Avonex) treatment.
    Waubant, Emmanuelle
    Goelz, Susan
    Deng, J.
    Lacy, Jo
    Bennett, J. R.
    Sandrock, Al
    Kantor, Aaron
    CLINICAL IMMUNOLOGY, 2006, 119 : S114 - S115
  • [29] T-cells expressing natural killer (NK) receptors are altered in multiple sclerosis and responses to α-galactosylceramide are impaired
    O'Keeffe, Joan
    Gately, Carol M.
    Counihan, Timothy
    Hennessy, Michael
    Leahy, Teresa
    Moran, Anthony P.
    Hogan, Edward L.
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2008, 275 (1-2) : 22 - 28
  • [30] ACTIVATED T-CELLS AND NATURAL-KILLER (NK) CELLS ARE NOT SEQUESTERED IN THE LIVER OF PATIENTS WITH PRIMARY BILIARY-CIRRHOSIS (PBC)
    HASHIMOTO, E
    LINDOR, KD
    LUDWIG, J
    HOMBURGER, HA
    DICKSON, ER
    HOLLEY, KE
    WIESNER, RH
    LARUSSO, NF
    CZAJA, AJ
    HEPATOLOGY, 1989, 10 (04) : 640 - 640